Is it Time to Dump Agile Therapeutics Inc (AGRX) Stock After it Is Lower By 9.31% in a Week?

Agile Therapeutics Inc (AGRX) stock has fallen 9.31% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Agile Therapeutics Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on AGRX!

See Full AGRX Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With AGRX Stock Today?

Agile Therapeutics Inc (AGRX) stock is trading at $2.63 as of 9:54 AM on Tuesday, Aug 8, a decline of -$0.02, or -0.75% from the previous closing price of $2.65. The stock has traded between $2.63 and $2.76 so far today. Volume today is less active than usual. So far 6,541 shares have traded compared to average volume of 53,573 shares.

More About Agile Therapeutics Inc

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin. Click Here to get the full Stock Report for Agile Therapeutics Inc stock.